SANDRA KASUMOVIC: Open Payments
NPI 1780009506 · CALDWELL, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $94 |
| Janssen Pharmaceuticals, Inc | 3 | $51 |
| Lundbeck LLC | 2 | $37 |
| Indivior Inc. | 2 | $35 |
| Alkermes, Inc. | 2 | $32 |
| Neos Therapeutics, LP | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: VRAYLAR, INVEGA SUSTENNA, ABILIFY ASIMTUFII, SUBLOCADE, ARISTADA, EXXUA, CAPLYTA.
Industry payments across ID — which companies pay providers there.
